Compare HIG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIG | ZTS |
|---|---|---|
| Founded | 1810 | 1952 |
| Country | United States | United States |
| Employees | 19200 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3B | 32.5B |
| IPO Year | N/A | 2012 |
| Metric | HIG | ZTS |
|---|---|---|
| Price | $142.71 | $77.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 12 |
| Target Price | $148.47 | ★ $154.18 |
| AVG Volume (30 Days) | 1.6M | ★ 4.4M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | 1.76% | ★ 1.86% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 1.42 |
| Revenue | N/A | ★ $9,467,000,000.00 |
| Revenue This Year | $6.05 | $5.63 |
| Revenue Next Year | $4.13 | $4.77 |
| P/E Ratio | ★ $10.61 | $53.55 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $120.33 | $71.47 |
| 52 Week High | $146.07 | $160.48 |
| Indicator | HIG | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 49.15 |
| Support Level | $128.94 | $73.42 |
| Resistance Level | $143.95 | $78.02 |
| Average True Range (ATR) | 3.36 | 1.95 |
| MACD | 0.21 | 0.46 |
| Stochastic Oscillator | 81.97 | 51.40 |
The Hartford Insurance Group Inc. provides property and casualty insurance, group benefits, and mutual funds. The company is widely recognized for its service excellence, sustainability practices, trust, and integrity. The Company currently conducts business principally in five reportable segments, including Business Insurance, Personal Insurance, Property & Casualty Other Operations, Employee Benefits, and Hartford Funds, as well as a Corporate category. The company generates a majority of its revenue from Business Insurance.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.